Michael Weintraub, MD
@mweintraubmd.bsky.social
Endocrinologist & Clin. Asst. Prof. @NYULangone | @WeillCornell and @Sloan_Kettering endocrine fellow alum. Opinions=own
#MedSky #EndoSky
#MedSky #EndoSky
There are multiple methods to estimate body composition, each with their pros and cons.
www.mdpi.com/2075-1729/14...
www.mdpi.com/2075-1729/14...
February 11, 2026 at 11:28 AM
There are multiple methods to estimate body composition, each with their pros and cons.
www.mdpi.com/2075-1729/14...
www.mdpi.com/2075-1729/14...
DEXA-derived estimates of abdominal adiposity in postmenopausal women was a better predictor of cardiometabolic disease than traditional surrogates (BMI, waist circumference, waist-to-hip ratio) in older women.
pubmed.ncbi.nlm.nih.gov/34479738/
pubmed.ncbi.nlm.nih.gov/34479738/
DXA Versus Clinical Measures of Adiposity as Predictors of Cardiometabolic Diseases and All-Cause Mortality in Postmenopausal Women - PubMed
DXA-derived estimates of abdominal adiposity in postmenopausal women may allow for substantially improved risk prediction of diabetes over standard clinical risk models. Larger DXA studies with…
pubmed.ncbi.nlm.nih.gov
February 9, 2026 at 2:54 PM
DEXA-derived estimates of abdominal adiposity in postmenopausal women was a better predictor of cardiometabolic disease than traditional surrogates (BMI, waist circumference, waist-to-hip ratio) in older women.
pubmed.ncbi.nlm.nih.gov/34479738/
pubmed.ncbi.nlm.nih.gov/34479738/
CagriSema demonstrates a1c reduction of 1.9% and weight loss of 14.2% in adults with type 2 diabetes, reported from the REIMAGINE 2 top-line data this week.
February 3, 2026 at 11:38 PM
CagriSema demonstrates a1c reduction of 1.9% and weight loss of 14.2% in adults with type 2 diabetes, reported from the REIMAGINE 2 top-line data this week.
Automated insulin delivery, the integration of insulin pump with continuous glucose monitor is now the standard of care for Type 1 Diabetes 🤖💉📈
Why? It’s clearly superior in attaining greater diabetes control by way of Time In Range ⏱️🩸✅
researchprofiles.ku.dk/en/publicati...
Why? It’s clearly superior in attaining greater diabetes control by way of Time In Range ⏱️🩸✅
researchprofiles.ku.dk/en/publicati...
January 25, 2026 at 6:14 PM
Automated insulin delivery, the integration of insulin pump with continuous glucose monitor is now the standard of care for Type 1 Diabetes 🤖💉📈
Why? It’s clearly superior in attaining greater diabetes control by way of Time In Range ⏱️🩸✅
researchprofiles.ku.dk/en/publicati...
Why? It’s clearly superior in attaining greater diabetes control by way of Time In Range ⏱️🩸✅
researchprofiles.ku.dk/en/publicati...
Milestones in research related to the pathophysiology of the incretin hormones GIP and GLP-1 as
parent compounds for incretin-based medications for treatment of type 2 diabetes and clinical obesity
pubmed.ncbi.nlm.nih.gov/41547366/
parent compounds for incretin-based medications for treatment of type 2 diabetes and clinical obesity
pubmed.ncbi.nlm.nih.gov/41547366/
January 22, 2026 at 3:48 PM
Milestones in research related to the pathophysiology of the incretin hormones GIP and GLP-1 as
parent compounds for incretin-based medications for treatment of type 2 diabetes and clinical obesity
pubmed.ncbi.nlm.nih.gov/41547366/
parent compounds for incretin-based medications for treatment of type 2 diabetes and clinical obesity
pubmed.ncbi.nlm.nih.gov/41547366/
What's new in ADA Standards of Care 2026?
Inclusion of continuous glucose monitoring (CGM) data when monitoring for disease progression among individuals with presymptomatic type 1 diabetes.
Recommendation 3.2 ADA Standards of Care 2026
diabetesjournals.org/care/article...
Inclusion of continuous glucose monitoring (CGM) data when monitoring for disease progression among individuals with presymptomatic type 1 diabetes.
Recommendation 3.2 ADA Standards of Care 2026
diabetesjournals.org/care/article...
January 14, 2026 at 5:42 PM
What's new in ADA Standards of Care 2026?
Inclusion of continuous glucose monitoring (CGM) data when monitoring for disease progression among individuals with presymptomatic type 1 diabetes.
Recommendation 3.2 ADA Standards of Care 2026
diabetesjournals.org/care/article...
Inclusion of continuous glucose monitoring (CGM) data when monitoring for disease progression among individuals with presymptomatic type 1 diabetes.
Recommendation 3.2 ADA Standards of Care 2026
diabetesjournals.org/care/article...
Mild autonomous cortisol secretion (MACS) is not a benign condition.
MACS carries increased risk of mortality with HR 1.52-1.77 compared to those with non-functioning adenomas, with death from cardiovascular disease, cancer and infection.
MACS carries increased risk of mortality with HR 1.52-1.77 compared to those with non-functioning adenomas, with death from cardiovascular disease, cancer and infection.
January 12, 2026 at 4:29 PM
Mild autonomous cortisol secretion (MACS) is not a benign condition.
MACS carries increased risk of mortality with HR 1.52-1.77 compared to those with non-functioning adenomas, with death from cardiovascular disease, cancer and infection.
MACS carries increased risk of mortality with HR 1.52-1.77 compared to those with non-functioning adenomas, with death from cardiovascular disease, cancer and infection.
How to manage Post-Bariatric Hypoglycemia (BPH), according to a new consensus statement
January 9, 2026 at 2:56 PM
How to manage Post-Bariatric Hypoglycemia (BPH), according to a new consensus statement
Mild autonomous cortisol secretion (MACS) traditionally viewed as part of the continuum of Cushing syndrome is recognized as a distinct entity.
Only <1% of MACS processes to overt Cushing syndrome.
Genetic mutations for MACS and Cushing syndrome is different
www.vumedi.com/video/when-a...
Only <1% of MACS processes to overt Cushing syndrome.
Genetic mutations for MACS and Cushing syndrome is different
www.vumedi.com/video/when-a...
January 7, 2026 at 4:17 PM
Mild autonomous cortisol secretion (MACS) traditionally viewed as part of the continuum of Cushing syndrome is recognized as a distinct entity.
Only <1% of MACS processes to overt Cushing syndrome.
Genetic mutations for MACS and Cushing syndrome is different
www.vumedi.com/video/when-a...
Only <1% of MACS processes to overt Cushing syndrome.
Genetic mutations for MACS and Cushing syndrome is different
www.vumedi.com/video/when-a...
Anabolic therapies hold tremendous potential for the treatment of osteoporosis. 💪🦴
Currently all treatments are injectables, but the are oral options on the horizon. 💉➡️💊
pubmed.ncbi.nlm.nih.gov/38578978/
Currently all treatments are injectables, but the are oral options on the horizon. 💉➡️💊
pubmed.ncbi.nlm.nih.gov/38578978/
November 26, 2025 at 4:59 PM
Anabolic therapies hold tremendous potential for the treatment of osteoporosis. 💪🦴
Currently all treatments are injectables, but the are oral options on the horizon. 💉➡️💊
pubmed.ncbi.nlm.nih.gov/38578978/
Currently all treatments are injectables, but the are oral options on the horizon. 💉➡️💊
pubmed.ncbi.nlm.nih.gov/38578978/
A practical side-by-side comparison of the Tymlos and Forteo, the two anabolic PTH receptor agonists for osteoporosis.
Presented by Dr. Bilezikian
Presented by Dr. Bilezikian
November 24, 2025 at 4:56 PM
A practical side-by-side comparison of the Tymlos and Forteo, the two anabolic PTH receptor agonists for osteoporosis.
Presented by Dr. Bilezikian
Presented by Dr. Bilezikian
In a world where a publication becomes outdated immediately after it's published, a recent systemic review shows incretin-based medications dominate clinical trial development. But they are not the only potential mechanism.
pubmed.ncbi.nlm.nih.gov/40993341/
pubmed.ncbi.nlm.nih.gov/40993341/
November 23, 2025 at 1:27 PM
In a world where a publication becomes outdated immediately after it's published, a recent systemic review shows incretin-based medications dominate clinical trial development. But they are not the only potential mechanism.
pubmed.ncbi.nlm.nih.gov/40993341/
pubmed.ncbi.nlm.nih.gov/40993341/
We should be screening everyone with hypertension for primary aldosteronism, according to the recently released Endocrine Society guidelines.
Follow this diagnostic algorithm
Full guidelines: academic.oup.com/jcem/article...
Follow this diagnostic algorithm
Full guidelines: academic.oup.com/jcem/article...
September 24, 2025 at 8:02 AM
We should be screening everyone with hypertension for primary aldosteronism, according to the recently released Endocrine Society guidelines.
Follow this diagnostic algorithm
Full guidelines: academic.oup.com/jcem/article...
Follow this diagnostic algorithm
Full guidelines: academic.oup.com/jcem/article...
How to individualize obesity medication treatment depending on obesity-related conditions.
Great summary by the newly released update to the AACE Evaluation and Treatment of Adults with Obesity 2025 Consensus Statement
www.endocrinepractice.org/article/S153...
Great summary by the newly released update to the AACE Evaluation and Treatment of Adults with Obesity 2025 Consensus Statement
www.endocrinepractice.org/article/S153...
September 19, 2025 at 6:15 PM
How to individualize obesity medication treatment depending on obesity-related conditions.
Great summary by the newly released update to the AACE Evaluation and Treatment of Adults with Obesity 2025 Consensus Statement
www.endocrinepractice.org/article/S153...
Great summary by the newly released update to the AACE Evaluation and Treatment of Adults with Obesity 2025 Consensus Statement
www.endocrinepractice.org/article/S153...
Developing clinical practice guidelines is quite a process.
The GRADE format methodology translates evidence to medication decision-making recommendations after performing systemic review of the available evidence.
www.bmj.com/content/389/...
The GRADE format methodology translates evidence to medication decision-making recommendations after performing systemic review of the available evidence.
www.bmj.com/content/389/...
September 8, 2025 at 3:14 PM
Developing clinical practice guidelines is quite a process.
The GRADE format methodology translates evidence to medication decision-making recommendations after performing systemic review of the available evidence.
www.bmj.com/content/389/...
The GRADE format methodology translates evidence to medication decision-making recommendations after performing systemic review of the available evidence.
www.bmj.com/content/389/...
A higher BMI is correlated with increased risk of overall mortality. It follows the same overall curve as higher cholesterol and blood pressure, as illustrated in these graphs 📈
Controlling any and all of these risk factors lowers our overall risk of death.
pubmed.ncbi.nlm.nih.gov/28489290/
Controlling any and all of these risk factors lowers our overall risk of death.
pubmed.ncbi.nlm.nih.gov/28489290/
August 25, 2025 at 12:39 PM
A higher BMI is correlated with increased risk of overall mortality. It follows the same overall curve as higher cholesterol and blood pressure, as illustrated in these graphs 📈
Controlling any and all of these risk factors lowers our overall risk of death.
pubmed.ncbi.nlm.nih.gov/28489290/
Controlling any and all of these risk factors lowers our overall risk of death.
pubmed.ncbi.nlm.nih.gov/28489290/
Obesity rates have skyrocketed starting in the 1970s now reaching 40% in the United States.
"It seems highly unlikely that the obesity epidemic can be explained by a widespread drop in willpower happening in the late 1970s."
www.cell.com/cell/fulltex...
"It seems highly unlikely that the obesity epidemic can be explained by a widespread drop in willpower happening in the late 1970s."
www.cell.com/cell/fulltex...
August 21, 2025 at 11:11 PM
Obesity rates have skyrocketed starting in the 1970s now reaching 40% in the United States.
"It seems highly unlikely that the obesity epidemic can be explained by a widespread drop in willpower happening in the late 1970s."
www.cell.com/cell/fulltex...
"It seems highly unlikely that the obesity epidemic can be explained by a widespread drop in willpower happening in the late 1970s."
www.cell.com/cell/fulltex...
A collection of all my favorite podcasts to stay up to date in Diabetes Care
Check out this Marvel-style crossover episode hosted at ADA.
overcast.fm/+AABFhuN39pM
Check out this Marvel-style crossover episode hosted at ADA.
overcast.fm/+AABFhuN39pM
Special Edition - ADA Scientific Sessions 2025 — Diabetes Core Update
In this special edition of Diabetes Core Update we present a special podcast recorded live at the ADA Scientific Sessions by the editors of Diabetes Core Update, Diabetes Care On Air, Diabetes Bio,…
overcast.fm
August 18, 2025 at 11:40 AM
A collection of all my favorite podcasts to stay up to date in Diabetes Care
Check out this Marvel-style crossover episode hosted at ADA.
overcast.fm/+AABFhuN39pM
Check out this Marvel-style crossover episode hosted at ADA.
overcast.fm/+AABFhuN39pM
Rates of obesity of BMI 30-40 have had a mild increase over the last 20 years.
Rates of severe obesity BMI > 60 has dramatically risen- this graph is impressive.
Slide by Dr. Satya Dash at #ENDO2025
Rates of severe obesity BMI > 60 has dramatically risen- this graph is impressive.
Slide by Dr. Satya Dash at #ENDO2025
July 13, 2025 at 11:55 PM
Rates of obesity of BMI 30-40 have had a mild increase over the last 20 years.
Rates of severe obesity BMI > 60 has dramatically risen- this graph is impressive.
Slide by Dr. Satya Dash at #ENDO2025
Rates of severe obesity BMI > 60 has dramatically risen- this graph is impressive.
Slide by Dr. Satya Dash at #ENDO2025
Pheochromocytoma survival curves are dismal, particularly in those with metastatic disease. We need better treatments for these patients.
Excellent lecture by Dr. Camilo Jimenez at #ENDO2025
Excellent lecture by Dr. Camilo Jimenez at #ENDO2025
July 13, 2025 at 4:48 PM
Pheochromocytoma survival curves are dismal, particularly in those with metastatic disease. We need better treatments for these patients.
Excellent lecture by Dr. Camilo Jimenez at #ENDO2025
Excellent lecture by Dr. Camilo Jimenez at #ENDO2025
Studies showing benefits of GLP1 agonists in type 1 diabetes are accumulating.
Modest A1c reduction but impressive reductions in total daily insulin dose and weight reduction.
#ENDO2025
Modest A1c reduction but impressive reductions in total daily insulin dose and weight reduction.
#ENDO2025
July 12, 2025 at 7:07 PM
Studies showing benefits of GLP1 agonists in type 1 diabetes are accumulating.
Modest A1c reduction but impressive reductions in total daily insulin dose and weight reduction.
#ENDO2025
Modest A1c reduction but impressive reductions in total daily insulin dose and weight reduction.
#ENDO2025
Retatrutide may be the most hotly anticipated GLP-1 based medication in development 🔥💊, but others are not far behind 🏃.
A triple agonist, UBT251, is under development in China 🇨🇳 and also mimics GLP-1, GIP, and glucagon 🧬⚗️.
A triple agonist, UBT251, is under development in China 🇨🇳 and also mimics GLP-1, GIP, and glucagon 🧬⚗️.
July 11, 2025 at 1:45 PM
Retatrutide may be the most hotly anticipated GLP-1 based medication in development 🔥💊, but others are not far behind 🏃.
A triple agonist, UBT251, is under development in China 🇨🇳 and also mimics GLP-1, GIP, and glucagon 🧬⚗️.
A triple agonist, UBT251, is under development in China 🇨🇳 and also mimics GLP-1, GIP, and glucagon 🧬⚗️.
“Food noise” is the “incessant mental chatter” or “constant rumination” about food.
It is increasingly recognized as a phenomenon particularly with its profound elimination with GLP1 treatment.
New Nature review: www.nature.com/articles/s41...
Great overview: conscienhealth.org/2025/07/lift...
It is increasingly recognized as a phenomenon particularly with its profound elimination with GLP1 treatment.
New Nature review: www.nature.com/articles/s41...
Great overview: conscienhealth.org/2025/07/lift...
July 9, 2025 at 12:16 PM
“Food noise” is the “incessant mental chatter” or “constant rumination” about food.
It is increasingly recognized as a phenomenon particularly with its profound elimination with GLP1 treatment.
New Nature review: www.nature.com/articles/s41...
Great overview: conscienhealth.org/2025/07/lift...
It is increasingly recognized as a phenomenon particularly with its profound elimination with GLP1 treatment.
New Nature review: www.nature.com/articles/s41...
Great overview: conscienhealth.org/2025/07/lift...